Skip to content
Recall Observatory FDA recall evidence

Drug product

Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06

D-0082-2018

October 30, 2017

Class III

Product summary

Firm
Jubilant Cadista Pharmaceuticals, Inc.
Event
Event 78461
Status
Terminated
Classification
Class III
Quantity
744 bottles
Official record key
drug-enforcement:D-0082-2018

Official wording

Reason: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Code information: Lot # 17P0430, Exp 05/19

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.